The objective of this document is to outline the requirements for a transcutaneous blood gas monitoring device designed for use in an elevated CO2 environment. This includes essential accessories such as a monitor, power supply options tailored for different countries, a sensor adapter cable, and a manual. Key specifications highlight the device's ingress protection rating of IPx2, necessary for ensuring safety against water ingress, and its versatility with a foldable handle and mounting options.
Two critical milestones are defined: the first involves creating a summary report on syncing the prototype with OCT2 Spectralis images and developing a high-level drawing of the prototype's fit within a drawer. The second milestone requires the delivery of the prototype to the Johnson Space Center (JSC) alongside training for laboratory personnel, alongside the necessary software and user manuals that address electrical and laser safety.
The timeline for the project spans from March 20, 2023, to September 22, 2023. The document identifies the device's lack of FDA clearance, highlighting its experimental nature and the critical need for further assessment and training prior to implementation.
The NASA Shared Services Center recommends negotiating a sole-source acquisition of equipment from Sentec due to its unique performance capabilities in elevated CO2 environments, essential for NASA's testing protocols. The rationale for this recommendation is that Sentec's equipment has been specifically tested for compatibility with NASA's conditions, while other brands have not undergone such rigorous evaluation. Should an alternative vendor or brand be considered, it would necessitate extensive new testing within NASA’s facilities, potentially delaying schedules tied to the Artemis missions. The report emphasizes the impracticality of competition for this procurement, citing both logistical and operational impacts. The estimated delivery period for the equipment is projected for April 2025. Overall, this document underscores the necessity of specialized equipment for NASA's critical missions, prioritizing reliability and established performance over broader market competition.
NASA/NSSC requires a Transcutaneous blood gas monitoring device for testing in high CO2 environments. They plan to award a sole source contract to SENTEC, INC., identified as the only provider capable of fulfilling this need. The procurement, under FAR guidelines, will take place at Johnson Space Center. The appropriate North American Industry Classification System (NAICS) code for this procurement is 39112. Interested parties have until 7 a.m. CST on March 3, 2025, to submit their qualifications in writing for consideration to determine if the procurement will proceed competitively. The government retains discretion over whether to seek competition based on received responses. Oral communications on the matter are not permitted. For concerns regarding the acquisition, the NASA Ombudsman is available at the designated web address. The primary contact for this procurement is Shanna Patterson, Procurement Specialist at NASA.